Navigation Links
Genaera to Present at Therapeutic Area Partnerships 2008
Date:10/30/2008

-Nominated as One of the Top 10 Most Interesting Metabolic Projects Available for Partnering-

PLYMOUTH MEETING, Pa., Oct. 30 /PRNewswire-FirstCall/ -- Genaera Corporation (NASDAQ: GENR) will present at the Windhover's Therapeutic Area Partnerships Conference being held November 3-5 at the Lowes Hotel in Philadelphia, Pennsylvania. Dr. Henry Wolfe, Executive Vice President and Chief Scientific Officer, will provide an overview on MSI-1436 for the treatment of type 2 diabetes and obesity on Tuesday, November 4, 2008 at 4:20 p.m. (ET).

About Genaera

Genaera Corporation is developing trodusquemine (MSI-1436), for type 2 diabetes and obesity currently in phase 1 clinical testing and has a fully out-licensed partnership with MedImmune, Inc. that is in phase 2 clinical testing in asthma. For further information, please see our website at http://www.genaera.com.

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties, known and unknown. Forward-looking statements reflect management's current views and are based on certain expectations and assumptions. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "believe," "continue," "develop," "expect," "plan" and "potential" or other words of similar meaning. Genaera's actual results and performance could differ materially from those currently anticipated and expressed in these and other forward-looking statements as a result of a number of risk factors, including, but not limited to the risks and uncertainties discussed in Genaera's filings
'/>"/>

SOURCE Genaera Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Genaera Receives Non-Compliance Notice From NASDAQ
2. Genaera Corporations 2008 Annual Stockholder Meeting Results
3. Xmark Comments on Genaera Cost-Saving Plan
4. Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph
5. Genaera Corporation Announces Licensing of Exclusive Rights to Pexiganan, a Novel Anti-Infective Drug Candidate, by Macrochem Corporation
6. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
7. Abbott to Present at 17th Annual Credit Suisse Health Care Conference
8. Derma Sciences to Present at The Rodman & Renshaw 10th Annual Healthcare Conference
9. CPC Appoints Medical Product Service GmbH as Authorized European Representative for MedClose(TM) System
10. Wound Management Technologies, Inc. Announces Strategic Business Directions, Recent Conference Presentation, in Addition to Symposium Exhibit Plans for Las Vegas
11. Cantel Medical Corp. to Present at the Oppenheimer & Co. 19th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... October 25, 2014 Market ... Diagnostics Industry, 2009-2019 is a professional and ... Molecular Diagnostics industry. The report firstly reviews ... its classification, application and manufacturing technology. The ... manufacturers of Molecular Diagnostics listing their product ...
(Date:10/25/2014)... (PRWEB) October 25, 2014 Mesothelioma researchers ... continued to receive pemetrexed (Alimta), after his combination drug ... the full story , just posted on the Surviving ... Uji Tokushukai Medical Center in Japan suggests that “maintenance ... mesothelioma patients who cannot tolerate higher doses of ...
(Date:10/25/2014)... Not getting the right amount of sleep might raise ... Those who sleep less or more than the ... more prone to developing the chronic condition, which causes ... concluded that duration and quality of sleep are key ... diseases. "Both short and long durations of sleep ...
(Date:10/25/2014)... HealthDay Reporter FRIDAY, Oct. 24, 2014 (HealthDay ... increased risks for certain cancers, one might think that high-risk ... a new study suggests that, at least with colon cancer, ... genes doubled their risk of colon cancer were no more ... "It didn,t make any difference, not at all," said study ...
(Date:10/22/2014)... October 22, 2014 On October 22, ... featuring skin diseases both fictional and real. The ... a nonprofit organization committed to advocacy and philanthropy in ... will take the opportunity to impart truth and clarity ... , There are many misconceptions about Morgellons Disease ...
Breaking Medicine News(10 mins):Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 3Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 4Health News:New Report Illustrates Extended Mesothelioma Survival with “Maintenance Therapy”, According to Surviving Mesothelioma 2Health News:Sleep Duration Linked to Ulcerative Colitis Risk in Study 2Health News:Knowing Genetic Risk for Cancer May Not Change Behavior 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3
... - Scientists from the Hebrew University have identified the molecular ... findings of this research have just been published in the ... the entire genetic information required for building the proteins of ... to changes in the cell function. These changes can lead ...
... of the brain,s master circadian clock known as the ... of rhythmic neural activity begins to decline by middle age. ... may have implications for the large number of older people ... "Aging has a profound effect on circadian timing," ...
... , TUESDAY, July 19 (HealthDay News) -- Following up ... for a long time have more gray matter in their ... shrink less as they age and they have stronger connections ... may better relay electrical signals, researchers said. "Our results ...
... triggering another, but explanations for that phenomenon have proved ... first neurobiological evidence that memories formed in the same ... episodic memory. The research was conducted by professor ... School of Arts and Sciences and graduate student Jeremy ...
... By Serena Gordon HealthDay Reporter , MONDAY, July 18 ... ride in a car driven by grandparents because they believe the ... But, new research suggests that children are actually safer in auto ... parent. As a matter of fact, the odds of ...
... , MONDAY, July 18 (HealthDay News) -- Melanoma, the ... by patients themselves, but new research reveals that self-detection ... In the study, conducted by researchers at Memorial ... found that in addition to higher rates of physician-detected ...
Cached Medicine News:Health News:Hebrew U. scientists identify molecular basis for DNA breakage 2Health News:Study shows new evidence of age-related decline in the brain's master circadian clock 2Health News:Study shows new evidence of age-related decline in the brain's master circadian clock 3Health News:Study shows new evidence of age-related decline in the brain's master circadian clock 4Health News:Study shows new evidence of age-related decline in the brain's master circadian clock 5Health News:Does Meditation Boost Brain Health? 2Health News:Penn researchers find neural signature of 'mental time travel' 2Health News:Kids Fare Better in Crashes When Grandparents Driving: Study 2Health News:Kids Fare Better in Crashes When Grandparents Driving: Study 3Health News:Specialists More Likely to Spot Deadly Skin Cancer 2
(Date:10/25/2014)... 24, 2014  America,s future engineers will connect ... at the  Medical Design and Manufacturing (MD&M) Minneapolis ... at the Minneapolis ... built robots from the "For Inspiration and Recognition ... and mentors will offer information to those curious ...
(Date:10/25/2014)... 2014  The National Association of Drug Diversion ... by Kentucky,s real-time, stop-sale ... National Precursor Log Exchange (NPLEx) system automatically blocks ... and helps flag meth offenders for law enforcement. ... NPLEx "watch lists" that notify them via email ...
(Date:10/25/2014)... Oct. 24, 2014 In conjunction with DURECT ... financial results press release, you are invited to listen ... over the internet on Monday, November 3, 2014 at ... A live audio webcast of the presentation will ... and clicking "Investor Relations."  If you are unable ...
Breaking Medicine Technology:Local robotics teams compete - a "FIRST" at next week's MD&M Minneapolis- October 29-30th at the Minneapolis Convention Center 2Local robotics teams compete - a "FIRST" at next week's MD&M Minneapolis- October 29-30th at the Minneapolis Convention Center 3Kentucky's NPLEx Technology Making Significant Progress 2DURECT Corporation Invites You to Join its Third Quarter 2014 Earnings Conference Call 2
... Leica M844 F40 with its new stand F19 ... allow on the one hand to homogenously move ... operate with a solid and stable microscope. The ... Chrome optics, stands on the same small footprint ...
... 2000 assays are designed ... IMMULITE 2000, a high-throughput, ... analyzer. IMMULITE 2000 offers ... and a rapidly expanding ...
... Detection Of Serum C-Peptide ... Measurement:, Evaluating patients ... Assisting in the classification ... Differentiating insulin dependent patients ...
Inquire...
Medicine Products: